5th CNS Drug Delivery Hilton Boston Logan Airport, Boston

As neuroscience R and D surges with investment to solve the field’s most pressing challenge, access to the brain, the 5th CNS Drug Development Summit will provide an unmissable showcase of the latest innovations to revolutionize therapeutic administration routes to the brain and optimize dose specificity. Join neuroscientists, neurobiologists, neuro-oncologists, protein engineers, biochemists, and CNS device experts from the likes of Roche, AbbVie, Takeda, Lundbeck, Sanofi, Biogen, Alnylam Pharmaceuticals and Bristol Myers Squibb this December as they reunite to translate their novel brain delivery technologies into the clinic.

Speakers: Adem Koksal, Scientific Director, Biologics Drug Discovery, Biogen, Allan Jensen, Vice President, Lundbeck, Aloïse Mabondzo, Co-Founder, CERES Brain Therapeutics, Anu Bhattacharyya, Executive Director, PTC Therapeutics, Bellos Hadjivassiliou, Senior Principal Scientist, Bristol-Meyers Squibb, Bryn Martin, Vice President, Research, Precision Delivery and CSF Sciences, Alcyone Therapeutics, Cheng-Chia Wu, Assistant Professor, Columbia University Irving Medical Center, Darin Falk, Chief Scientific Officer, Lacerta Therapeutics, Didier Lefebvre, Research Fellow, Abbvie, Felix Schumacher, Program Leader Targeted Therapeutics, Roche, Fergus Quigley, Director, Device Development Leader (Early Stage), Takeda, Habib Baghirov, Scientific Lead, Roche and more.